| # | Drug | Count |
|---|---|---|
| 0 | BLINATUMOMAB | 35 |
| 1 | CYTARABINE | 15 |
| 2 | DEXAMETHASONE | 15 |
| 3 | DEXAMETHASONE 1.5 MG | 15 |
| 4 | CYCLOPHOSPHAMIDE | 14 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 14 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 14 |
| 7 | FLUDARABINE PHOSPHATE | 11 |
| 8 | INOTUZUMAB OZOGAMICIN | 9 |
| 9 | METHOTREXATE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BLINATUMOMAB | 35 | 0.0033 |
| 1 | INOTUZUMAB OZOGAMICIN | 9 | 0.0030 |
| 2 | REVUMENIB | 2 | 0.0019 |
| 3 | CLOFARABINE | 2 | 0.0009 |
| 4 | MOMELOTINIB | 1 | 0.0007 |
| 5 | MITOXANTRONE HYDROCHLORIDE | 4 | 0.0006 |
| 6 | GEMTUZUMAB OZOGAMICIN | 2 | 0.0005 |
| 7 | FLUDARABINE PHOSPHATE | 11 | 0.0003 |
| 8 | ISAVUCONAZONIUM SULFATE | 1 | 0.0003 |
| 9 | CYTARABINE | 15 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 9 | 0.0030 |
| 1 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 2 | Topoisomerase Inhibitor [EPC] | 6 | 0.0001 |
| 3 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 17 | 0.0001 |
| 6 | Alkylating Drug [EPC] | 14 | 0.0001 |
| 7 | BCL-2 Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 7 | 0.0000 |